106-9 Kicks Country #1 For New Country
With $628 million from the U.S. government, Emergent Bio-Solutions in Baltimore is scaling up separate Johnson & Johnson and AstraZeneca COVID-19 vaccines, which are still pending FDA approval. Source
Thursday, February 13, 2025
With $628 million from the U.S. government, Emergent Bio-Solutions in Baltimore is scaling up separate Johnson & Johnson and AstraZeneca COVID-19 vaccines, which are still pending FDA approval. Source
If you need assistance accessing our public file, please contact Larry Stone at (931) 528-6064.
